Evaluating Personalized (N-of-1) Trials in Rare Diseases: How Much Experimentation Is Enough? is a research paper published in PubMed (2022). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: UL1 TR001873
NIMH NIH HHS
Grant: R01 MH109496
NLM NIH HHS
Grant: R01 LM012836
NIA NIH HHS
Grant: P30 AG063786
National Institutes of Health
Grant: 5R01LM012836-05
Re-engineering Precision Therapeutics Through N-of-1 Trials
National Institutes of Health
Grant: 1P30AG063786-01
Roybal Center for Personalized Trials: Physical Activity Promotion to Foster Healthy Aging
National Institutes of Health
Grant: 3UL1TR001873-07S1
Clinical and Translational Science Award
National Institutes of Health
Grant: 5R01MH109496-03
Novel Methods for Evaluation and Implementation of Behavioral Intervention Technologies for Depression
FWCI
1.64
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals